Articles tagged with Cancer Screening
Screening for colorectal cancer is vital for early detection, with a significant reduction in mortality rates associated with early detection. Current techniques like colonoscopy are effective but expensive, prompting the need for alternative methods.
As new genetic components are identified, clinical services must adapt to cope with the increasing demand. The role of genetic information in managing inherited cancers is becoming increasingly important, enabling tailored therapies for individual patients.
Research found that approximately 20% of the breast cancers detected by screening mammography were ductal carcinoma in situ (DCIS), and the rate of DCIS diagnoses per 1000 mammograms increased with age. Mammograms were also more sensitive at detecting DCIS than invasive breast cancer.
A study published in the Journal of the National Cancer Institute found that 20% of mammogram-detected breast cancers are in situ lesions with unknown aggressiveness. The research highlights the need for further understanding of DCIS to identify which cases may progress to invasive cancer.
A study found that visual inspection with acetic acid (VIA) and HPV DNA testing are less expensive alternatives to traditional Pap smear screening for cervical cancer in developing countries. VIA, performed every 5 years in women ages 35-55, was the least expensive approach and saved the most lives.
The National Lung Cancer Screening Trial (NLST) is a randomized, controlled study aiming to determine the effectiveness of spiral CT scans versus chest X-rays in reducing deaths from lung cancer. Participants will receive annual screenings for three years and their health will be monitored until 2009.
Researchers develop surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI) for identifying potential biomarkers of early stage breast cancer. The study achieved high sensitivity and specificity, suggesting SELDI may lead to the discovery of additional biomarkers.
A study finds that PSA testing led to a 29% and 44% overdiagnosis rate among white and black men, respectively. The increased incidence was partly due to unnecessary biopsies and side effects from treatment.
Researchers argue that the NY-ELCAP program cannot determine if screening saves lives due to a lack of control group. The study may harm participants, lead to overdiagnosis and make it harder to learn the true effect of spiral CT screening.
Only 60.5% of US adults are fully protected against diphtheria and 72.3% against tetanus, with disparities among age groups and ethnicities. Reorganizing physician practices to prioritize preventive services can increase immunization rates.
The grant will allow Rush to increase awareness among African-American men aged 50+, who are disproportionately affected by prostate cancer. The organization plans to conduct free screenings and refer patients to local doctors or Rush after diagnosis.
A recent study by ECCO-the European CanCer Organisation suggests that a significant proportion of interval breast cancers may be detectable during screening, potentially improving detection rates. The researchers reviewed 723 mammograms and found that 27% of previously undetected cancers could have been detected during screening, corre...
Innovative programs addressing infant mortality, cancer screening and management, cardiovascular disease, diabetes, HIV/AIDS, and immunization show promise. Community-based initiatives, including churches, prisons, and barber shops, are key to building trust and addressing socio-economic factors contributing to health disparities.
A study found that hormone replacement therapy use is associated with a higher risk of dense breasts and interval cancers. Women who had used HRT were more likely to have dense breasts and cancers detected between screenings.
Evidence suggests PSA screening may not significantly reduce prostate cancer mortality rates. Large-scale randomized controlled trials are necessary to confirm these findings and provide clarity on the effectiveness of PSA screening at a population level.
A study found that women are more likely to get regular cancer screenings if they have a well-organized primary care system. Women in private HMOs were also more likely to receive regular screenings compared to uninsured or underinsured women.
A Dartmouth study found biases in cancer screening trials that may have overestimated its benefits, suggesting a need for alternative mortality analysis methods. The research recommends using all-cause mortality alongside disease-specific mortality to ensure accurate assessment of screening's value.
A study found that two forms of bias in cause-of-death classification affect the results of randomized trials on cancer screening. Sticky-diagnosis bias biases against screening, while slippery-linkage bias biases in favor of screening. The authors suggest using all-cause mortality to accurately assess the value of screening.
Researchers at the Fred Hutchinson Cancer Research Center have developed a new cell-based approach for anticancer drug discovery, which identified 39 new compounds selective for yeast cells with faulty DNA repair enzymes. This approach is adaptable to high-throughput screening methods and complements target-based screening, potentially...
A retrospective study found that 87% of smokers who underwent low-dose CT scanning for lung cancer screening reported an increase in motivation to quit. Twenty-three percent of participants quit smoking after screening, with a median time between screening and quitting being six months.
Prostate cancer screening is a contentious issue due to its potential impact on quality of life and the need for well-informed decision-making. The article highlights the limitations of current research, including the lack of data on risk-benefit analysis and the importance of avoiding unnecessary anxiety and treatment.
Screening for colorectal cancer could lead to a 20% reduction in mortality rates, but its effectiveness depends on various factors. The UK government has set up pilot centres to evaluate the potential of faecal occult blood testing (FOBT) as a screening method.
Research suggests that bowel cancer screening strategies targeting solely individuals with a family history may have limited impact on reducing mortality from colorectal cancer. In fact, the study found that around 85% of bowel cancers develop in people without a family history, highlighting the need for more widespread screening.
A new test combining a vinegar solution with an HPV test accurately detects precancerous lesions and reduces false positives among African women, potentially saving thousands of lives. The test could be easily administered at home or in clinics, making it a game-changer for cervical cancer screening in developing countries.
A study found that nearly one-third of primary care physicians do not discuss cancer screenings with their patients, citing lack of time and language barriers. The survey also revealed that many doctors would make decisions independently of patient preference, and some were less likely to discuss controversial tests like PSA measurements.
Idun Pharmaceuticals recreates key apoptosis reaction to understand mechanism of programmed cell death. The company screens new drugs modulating apoptosis using the assay, aiming to treat cancers, heart attacks, and strokes.
A new study from UCSF found that postmenopausal women with normal Pap smear results may not need annual screening, as the benefits are small and the risk of false-positive testing is high. Researchers also discovered that hormone replacement therapy did not significantly affect cervical cellular abnormalities.
A new study by UCSF/SFVAMC researchers found that mammography is equally effective in detecting breast cancer in women with and without a family history. The study analyzed data from over 389,000 women and showed that mammography detects nearly 85% of cancers in women aged 50-69, regardless of family history.
A new study by University of North Carolina at Chapel Hill researchers shows that watching a videotape explaining colon cancer procedures can increase screening rates by at least 15%. This could lead to significant reductions in deaths from colorectal cancer, with over 47,000 Americans dying annually.
Healthcare personnel working in poorly ventilated general hospital rooms were at risk for sero-conversion of tuberculosis. Improving ventilation to at least two air exchanges per hour can help prevent this risk. Additionally, a program using an educational videotape and brochure increased colon cancer screening rates among patients.
A study found that women aged 52-69 who do not receive regular mammograms or Pap smears cite similar barriers to screening, including fears about embarrassment and inaccurate tests. The researchers recommend tailored interventions to address these misconceptions.
Randomized trials demonstrate the effectiveness of mammography programs in reducing breast cancer mortality. The studies showed that recall rates after first and subsequent screens were 9.5% and 4.6%, respectively. Additionally, organized breast cancer screening programs can provide more comprehensive monitoring for at-risk populations.
Mayo Clinic researchers developed a new, non-invasive DNA test that detected 91% of colorectal cancers and 73% of polyps. The test shows promise for reducing unnecessary colonoscopies and costs associated with colorectal cancer screening.
A mathematical model suggests that one-time colonoscopy at age 55 can significantly reduce colorectal cancer mortality. The study found that this strategy is cost-effective and can achieve up to 50% reduction in CRC mortality, depending on compliance.
Women taking tamoxifen for breast cancer prevention don't need regular uterine biopsies to detect early endometrial cancer. Abnormal vaginal bleeding is a more effective indicator of the rare but curable condition.
Two studies found that common screening techniques for tamoxifen-induced endometrial cancer are ineffective. Tissue biopsies and transvaginal ultrasound screenings detected few abnormalities and led to unnecessary procedures. Patients should be reassured and monitored for abnormal vaginal bleeding instead.
A study found that physician encouragement and accurate information about colorectal cancer risks increased women's willingness to undergo screening. Women who were urged by their physicians to be screened had a substantially higher rate of recent screening, with 64% participating in the previous two years.
A new study from the University of North Carolina at Chapel Hill suggests that current PSA screening strategies should be changed. Testing men at ages 40 and 45, and then every two years after age 50, may prevent more deaths than waiting until age 50.
A study found that breast cancer mortality was almost identical in two groups of women aged 50-59, one receiving annual mammograms and the other physical examinations alone. Effective and regular breast physical examinations with breast self-examination may be an alternative to annual mammograms for this age group.
A US study found that women with recent normal Pap smear results have a similar low rate of significant cellular abnormalities regardless of the time interval between screenings. The study suggests that some women may not need to be screened annually, and that less frequent screening may be safe for low-risk women.
Two studies found sigmoidoscopy detects few cancerous growths and none in asymptomatic patients with polyps, supporting the use of colonoscopy for regular screening. The research suggests that colonoscopy should be done every 5-10 years for people over 50 to save lives.
A study found that inner-city physicians provide fewer cancer screenings and preventive services compared to higher-income communities. The researchers identified four main barriers: lack of training, time constraints, office support, and insurance reimbursement issues.
A new study predicts that anal Pap smear screening every two to three years would detect pre-cancerous lesions among high-risk HIV-negative men and allow for early treatment of anal cancer. The analysis suggests that this simple procedure could save lives at a cost comparable to annual mammography.
New antidepressant guidelines suggest both older and newer medications are effective in treating depression. A population-based study found that overweight women are less likely to receive screening for cervical and breast cancer, despite higher mortality rates from these cancers.
Researchers have identified three recurrent BRCA1 mutations in Polish breast-ovarian cancer families, suggesting founder mutations. These mutations, 5382insC, C61G, and 4153delA, account for 82% of the study's findings, enabling more efficient screening and diagnosis.
A study found that only 15% of women in prison had undergone cervical cancer screening, despite 75% being willing to receive it. Short stays and urgent medical needs contribute to this disparity. Improved medical care could reduce the burden of ill health later on.
A University of California, San Francisco study found that screening mammography in elderly women aged 66-79 reduced their risk of developing metastatic breast cancer by 43% compared to those who were not screened. This is the first evidence that mammography is beneficial for these women.
A self-collected test for human papilloma virus (HPV) is as sensitive as Pap smears in detecting cancerous and pre-cancerous lesions of the cervix. The test has shown promise in increasing cervical cancer screenings in both developed and developing worlds.
A new study by UCSF researchers suggests that screening for breast cancer in elderly women may not be worth the cost, citing a small increase in life expectancy. The study also highlights the potential downsides of mammograms, including false positives and anxiety caused by abnormal results.
A new study reveals that social network characteristics and healthcare provider recommendations significantly influence women's breast cancer screening practices. The research found that women who perceive regular mammography as common among their peers are more likely to get screened regularly.
Researchers advocate for standardized examination techniques to improve physicians' precision and accuracy in screening for breast cancer. The study found that spending adequate time on the clinical breast examination (CBE) and using proper techniques can increase early detection of lumps in the breast.
A new computer model suggests that more frequent mammogram screenings can dramatically reduce breast cancer deaths. The study found that prompt annual screening could result in a 51% reduction in breast cancer deaths, with twice-yearly screenings potentially cutting death rates by as much as 80%.
A new study predicts that regular anal Pap smear screenings can lead to early detection of pre-cancerous lesions and treatment of anal squamous cell cancer among high-risk men. The screening is estimated to be cost-effective, saving an average of $16,000 per year of life gained.
A new test using vinegar and visual inspection detected over 75% of potential cancers among African study participants, identifying almost twice as many cases as Pap smears. The inexpensive and easy test could provide a reliable screening option for women in developing countries where cervical cancer is prevalent.
A new study finds that digital mammography provides better information for diagnoses, allowing radiologists to use multiple views of images. The technology has the potential to lead to earlier tumor detection and treatment, reducing breast cancer mortality rates.
A study of eight large clinical trials found that mammography screenings for women in their 40s add only about five days to life expectancy and may not significantly reduce breast cancer deaths. However, the overwhelming proportion of women experience no benefit from screening.
Researchers analyzed data from over 72,000 screening mammograms to show a steady increase in cancer detection across all ages, with no abrupt jump at 50. The study challenges previous conclusions that suggested an age-related change in mammography's effectiveness, supporting the continued use of screening for women aged 40-49.
Women in their 40s benefit more from annual mammography screening due to detectable cancers being larger and more aggressive. Mammograms for younger women are less effective compared to breast palpation, which also faces similar limitations in denser pre-menopausal breasts.
Mathematical models identify optimal locations for breast cancer screening centers in Montreal, balancing medical excellence with geographic accessibility. The study suggests that reducing the number of centers from 48 to 15-22 guarantees high standards while maintaining access for women.
Researchers found that annual mammograms and clinical breast exams can lead to high false-positive rates, causing unnecessary anxiety and costly follow-up tests. The study suggests that up to 16 million US women may experience a false-positive result after 10 years of screening.